公开(公告)号：US10561633B2

公开(公告)日：2020-02-18

申请号：US15329062

申请日：2015-07-26

Applicant: Symrise AG

Inventor： Veronika Somoza ,  Barbara Rohm ,  Kathrin Liszt ,  Marc Pignitter ,  Christina Hochkogler ,  Jakob Ley ,  Sabine Widder ,  Gerhard Krammer

IPC: A61K31/352 ,  A23L33/10 ,  A23C23/00 ,  A23G3/36 ,  A23G4/06 ,  A23L2/52 ,  C07D311/30

Abstract: The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.

公开(公告)号：US20170135982A1

公开(公告)日：2017-05-18

申请号：US15329062

申请日：2015-07-26

Applicant: Symrise AG

Inventor： Veronika Somoza ,  Barbara Rohn ,  Kathrin Liszt ,  Marc Pignitter ,  Christina Hochkogler ,  Jakob Ley ,  Sabine Widder ,  Gerhard Krammer

IPC: A61K31/352 ,  A23L33/10 ,  A23C23/00 ,  A23G4/06 ,  A23G3/36 ,  C07D311/30 ,  A23L2/52

CPC classification number: A61K31/352 ,  A23C23/00 ,  A23G3/36 ,  A23G4/06 ,  A23L2/52 ,  A23L33/10 ,  A23V2002/00 ,  C07D311/30

Abstract: The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.